Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
Brigham and Women's Hospital · Harvard University
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
807
total citations
- FWCI
- 84.97
- Percentile
- 100%
- References
- 14
Citations per year
Authors
5- PMPaul M. RidkerCorresponding
Brigham and Women's Hospital, Harvard University
- ADAruna D. Pradhan
Harvard University, Brigham and Women's Hospital
- JMJean MacFadyen
Harvard University, Brigham and Women's Hospital
- PLPeter Libby
Brigham and Women's Hospital, Harvard University
- RJRobert J. Glynn
Brigham and Women's Hospital, Harvard University
Topics & keywords
Topics
Keywords
- Medicine
- Diabetes mellitus
- Rosuvastatin
- Internal medicine
- Clinical endpoint
- Hazard ratio
- Statin
- Unstable angina
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.